How to take Lorlatinib

Lorlatinib/Lorlatinib is a third-generation anaplastic lymphoma kinase (ALK) inhibitor with anti-tumor activity in patients with previously treated ALK-positive non-small cell lung cancer. How to take lorlatinib.

Take strictly as prescribed by your doctor Laolatinib, Follow all directions on the prescription label, and read any medication guides or inserts. When taking lorlatinib, swallow the tablet whole without crushing, chewing, or breaking it and take it at the same time each day with or without food. . Store tabletsat room temperature, away from moisture and heat.

The usual adult dose for non-small cell lung cancer is 100 mg taken orally once daily. Treatment should be continued until disease progression or unacceptable toxicity occurs. Mild or moderate renal insufficiency(CrCl 30to89ml/minutes)Patients not recommended to adjust dosage, severe renal insufficiency(CrCl 15to less than30ml/minutes)The recommended dose for patients is 75mg taken orally once daily . For patients who experience adverse reactions, the first dose is reduced to 75orally once a day, and the second dose is reduced to 50mg orally once a day. Patients who cannot tolerate 50mg orally once a day should permanently discontinue treatment. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.

xa0